NCT01970995View on ClinicalTrials.gov

Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

November 30, 2014

Conditions
Smoking
Interventions
OTHER

THS 2.2 Menthol (mTHS 2.2)

THS 2.2 Menthol ad libitum for 5 days in confinement prolonged by 85 days in an ambulatory setting

OTHER

Smoking Abstinence (SA)

SA for 5 days in confinement prolonged by 85 days in an ambulatory setting

OTHER

Menthol Conventional Cigarette (mCC)

Subject's own preferred brand of mCC ad libitum for 5 days in confinement prolonged by 85 days in an ambulatory setting

Trial Locations (1)

Unknown

Osaki Hospital Tokyo Heart Center, 5-4-12, Kitashinagawa, Shinagawa-ku, Tokyo

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT01970995 - Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting | Biotech Hunter | Biotech Hunter